The loss of Brg1 and/or Brm can foster cancer development via the down-regulation (as measured by qPCR) of 27 potential anticancer genes from at least 8 categories (tumor suppressor, immunity, drug metabolism, DNA repair, differentiation, apoptosis, cell adhesion and metabolism). This evidence concerns the gene SMARCA4 and cancer.